Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Clinical trial NCT00473954 · COMPLETED

Trial details

NCT number: NCT00473954
Sponsor: EGEN, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Neoplasms

Start date: 2007-04-01
Primary completion: 2009-11-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.